A contact lens that can measure intraocular pressure and deliver a glaucoma treatment when needed has been reported in the journal Nature Communications.
Glaucoma is a group of eye diseases which can lead to irreversible vision loss. According to Glaucoma Australia, two in 100 Australians will develop glaucoma in their lifetime, and there is no known cure.
Vision loss in glaucoma is usually caused by changes to intraocular pressure (IOP) due to abnormal circulation of the aqueous humour – a clear fluid that circulates within the eye. High intraocular pressure can damage the optic nerve which carries signals from the eye to the brain, leading to vision loss.
Currently, the main treatments for glaucoma management include prescription eyedrops and surgery, which both work to reduce the intraocular pressure. However, intraocular pressure also varies from person to person and over time depending on, for example, our circadian rhythm.
Read more: Butterfly wing inspires nanotech glaucoma sensor
According to the report, scientists have developed a contact lens that uses electrical sensing to measure real-time intraocular pressure. When the pressure reaches a high-risk threshold, a drug delivery module in the contact lens can apply an anti-glaucoma drug to the eye as needed.
The contact lens is an example of a so-called “theranostic device” – one that combines diagnostics and therapeutics – in other words, both recognising and treating the disease.
The design includes an intraocular pressure sensor and a wireless transfer power circuit sandwiched between upper and lower contact lenses, allowing the lens to function without wires or batteries.
The contact lens has so far been tested in pig and rabbit eyes, while clinical applications in humans still require further research.
“This smart system provides promising methodologies that could be expanded to other ophthalmic diseases,” the authors write in the new paper.
Originally published by Cosmos as A smart contact lens to treat glaucoma can measure eye pressure and deliver drug as needed
Matilda Handsley-Davis
Matilda is a science writer at Cosmos. She holds a Bachelor of Arts and a Bachelor of Science (Honours) from the University of Adelaide.
Read science facts, not fiction...
There’s never been a more important time to explain the facts, cherish evidence-based knowledge and to showcase the latest scientific, technological and engineering breakthroughs. Cosmos is published by The Royal Institution of Australia, a charity dedicated to connecting people with the world of science. Financial contributions, however big or small, help us provide access to trusted science information at a time when the world needs it most. Please support us by making a donation or purchasing a subscription today.
